代谢综合征对因BPH而导致的LUTS组合疗法的影响:一项前性研究
Iqbal Singh1, Himanshu Agrawal2, Vidhi Maurya2
1Department of Surgery (Urology), University College of Medical Sciences (University of Delhi) & GTB Hospital, Delhi, 110095, India.
The Canadian journal of urology
|September 5, 2025
概括
代谢综合征对良性前列腺增生 (BPH) 下尿道症状 (LUTS) 的联合治疗产生负面影响. 与没有代谢综合征的患者相比,代谢综合症患者的症状缓解和流量改善较小.
科学领域:
- 泌尿外科
- 代谢综合征研究
- 药物治疗的结果
背景情况:
- 良性前列腺增生 (BPH) 是老年男性普遍存在的疾病,通常与下泌尿道症状 (LUTS) 相关.
- 代谢综合征 (MtS) 越来越多地被认为是一种具有潜在系统影响的多因素疾病.
- 需要精确评估MtS对与BPH相关的LUTS联合药物治疗的疗效的影响.
研究的目的:
- 研究同时存在的代谢综合征 (MtS) 对由于良性前列腺增生 (BPH) 的下尿道症状 (LUTS) 治疗结果的影响.
- 评估Tamsulosin和Dutasteride组合药物治疗在有或没有MtS的BPH患者中的疗效.
- 提供数据,以便在LUT- BPH患者的联合治疗方面作出明智的临床决策.
主要方法:
- 这是一项前性研究,涉及70名因BPH而患有LUTS的合格男性患者,分为有或没有MtS的组.
- 患者接受了为期2个月的含有塔姆苏林和杜塔斯特的联合药物治疗.
- 通过国际前列腺症状评分 (IPSS),平均流量 (MFR) 和尿量峰值 (Qmax) 的变化来评估结果.
主要成果:
- 对照组 (没有MtS) 与MtS组相比,IPSS在统计上显著降低 (p < 0. 001).
- 观察到平均流量 (MFR) 改善的显著差异,有利于对照组 (p < 0. 001).
- 虽然两组都显示出尿量峰值 (Qmax) 的显著变化,但两组之间的改善差异没有统计学意义 (p = 0. 829).
结论:
- 代谢综合征对由于BPH而导致的LUTS组合药物治疗的结果产生不利影响.
- 患有LUTS- BPH和同时存在的MtS的患者可能会出现症状减轻和流量改善.
- 泌尿科医生应在选择和咨询患者进行LUTS- BPH组合治疗时考虑MtS状态.
更多相关视频
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
322
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
322
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Combined Effects of Drugs: Synergism
4.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.7K
Oral Hypoglycemic Agents: Biguanides and Glitazones
288
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
288
Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Hypertension IV: Drug Therapy and Lifestyle Modifications
37
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
37


